APOL1
Basic information
Region (hg38): 22:36253071-36267530
Previous symbols: [ "APOL" ]
Links
Phenotypes
GenCC
Source:
- focal segmental glomerulosclerosis 4, susceptibility to (Strong), mode of inheritance: AR
- focal segmental glomerulosclerosis 4, susceptibility to (Definitive), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (98 variants)
- not_specified (59 variants)
- Focal_segmental_glomerulosclerosis_4,_susceptibility_to (25 variants)
- APOL1-related_disorder (14 variants)
- Focal_segmental_glomerulosclerosis (3 variants)
- Hyalinosis,_Segmental_Glomerular (3 variants)
- Nephrotic_range_proteinuria (3 variants)
- Glomerulonephritis (2 variants)
- Steroid-resistant_nephrotic_syndrome (2 variants)
- APOL1-associated_kidney_disease (2 variants)
- Sickled_erythrocytes (2 variants)
- Proteinuria (2 variants)
- Corticosteroids_response (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APOL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003661.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 31 | 32 | ||||
missense | 79 | 12 | 98 | |||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 0 | 1 | 83 | 43 | 8 |
Highest pathogenic variant AF is 0.0114035
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APOL1 | protein_coding | protein_coding | ENST00000319136 | 6 | 14521 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000514 | 0.254 | 125721 | 0 | 27 | 125748 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.583 | 259 | 234 | 1.11 | 0.0000126 | 2701 |
Missense in Polyphen | 70 | 57.422 | 1.219 | 745 | ||
Synonymous | -0.952 | 104 | 92.4 | 1.13 | 0.00000539 | 816 |
Loss of Function | -0.0236 | 8 | 7.93 | 1.01 | 3.36e-7 | 92 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.000496 | 0.000496 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in lipid exchange and transport throughout the body. May participate in reverse cholesterol transport from peripheral cells to the liver.;
- Disease
- DISEASE: Focal segmental glomerulosclerosis 4 (FSGS4) [MIM:612551]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:20635188, ECO:0000269|PubMed:20647424}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- African trypanosomiasis - Homo sapiens (human);Vesicle-mediated transport;Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors
(Consensus)
Intolerance Scores
- loftool
- 0.976
- rvis_EVS
- 1.45
- rvis_percentile_EVS
- 95.12
Haploinsufficiency Scores
- pHI
- 0.0163
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.390
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.417
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Zebrafish Information Network
- Gene name
- apol1
- Affected structure
- podocyte
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- lipid transport;receptor-mediated endocytosis;cholesterol metabolic process;cytolysis;killing of cells of other organism;lipoprotein metabolic process;post-translational protein modification;cellular protein metabolic process;innate immune response;chloride transmembrane transport
- Cellular component
- extracellular region;extracellular space;endoplasmic reticulum lumen;intrinsic component of membrane;very-low-density lipoprotein particle;high-density lipoprotein particle;blood microparticle
- Molecular function
- chloride channel activity;protein binding;lipid binding